Health
COVID-19 survivors urged to donate blood for trials – The Australian Financial Review
Men recovering from COVID-19 are being urgently sought to donate their antibodies for two treatment trials to help acute hospitalised patients.
The other, REMAP-CAP, focuses on critically ill COVID-19 patients who require intensive care. Convalescent plasma is being used with antiviral medications, immune function modulators, anti-coagulation therapy to assess the impact on acute patients.
Anyone who has had COVID-19 but has been free of it for 28 days is eligible to donate. “We would encourage people to come forward,” Dr Daly said.
Men who are recovering from COVID-19 are being sought in particular, because research suggests they hav…
-
Noosa News13 hours agoFormer NRL player Teui ‘TC’ Robati lured woman to pub toilet before alleged rape, jury told
-
Noosa News21 hours agoCattle claimants ‘bitterly disappointed’ after court downplays compensation claim from live export ban
-
General18 hours agoArtificial intelligence could help plan cities, but there are downsides
-
General13 hours agoGetty argues its UK copyright case does not threaten AI